The next day May 26th at 13:45 (Canary time), the General Council of Official Colleges of Pharmacists, with the sponsorship of Lilly and Novo Nordisk, will hold the online training session titled «Obesity: What are the main contributing factors and the newest treatments?» addressed to all interested pharmacists and other healthcare professionals.
OBJECTIVES
During this session, which will be led by a physician and a pharmacist-nutritionist, the main new developments in therapeutics and the multidisciplinary approach to people living with obesity will be discussed, based on two real-life cases from different care settings. The key takeaways will be provided from a very practical perspective. This is the second of three mini-webinars in the health campaign “Obesity: Beyond Weight. The Pharmacy's Key Role in Prevention and Management,” which is taking place between March and September 2025.
PARTICIPANTS
- Raquel Varas Doval Pharmaceutical. Head of the Health Campaigns Area of the General Council of Official Colleges of Pharmacists.
- Christopher Morales. Endocrinology and Nutrition Specialist Doctor at Vithas Hospital in Seville, and board member of SEEDO (Spanish Obesity Society).
- Felipe Mozo. Community pharmacist and nutritionist in Cádiz. Regional Governor of Nutrition. Vice-president of the COF of Cádiz. Researcher at INiBICA CO1-INMOX Group (Inflammation, Nutrition, Metabolism, and Oxidative Stress).
The session will be held using the “GoToWebinar” tool, which allows questions to be asked through the enabled chat functionality.
More information Clicking here.
The session will be available later in that space, as well as on the YouTube channel of the General Council.
